SABCS 2019
Vogl, NY: Oral Paclitaxel—Handle with Care and Skepticism
At least 4 reasons exist for clinicians and federal agencies to question the results presented to date.
MAY 18, 2020
Oral Paclitaxel Beats IV Paclitaxel in Response Rate, OS
Oral paclitaxel combined with encequidar (Athenex)—a minimally absorbed, highly specific, potent inhibitor of ...
FEBRUARY 4, 2020
WHI Trials Provide New Data on Hormone Therapy for Breast Cancer
After nearly half a century, hormone therapy’s influence on breast cancer incidence and mortality remains ...
JANUARY 8, 2020
Load more